Anteris Technologies Global (NASDAQ:AVR – Get Free Report) is projected to post its Q1 2026 results before the market opens on Tuesday, May 12th. Analysts expect Anteris Technologies Global to post earnings of ($0.1563) per share and revenue of $0.85 million for the quarter. Individuals can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Monday, May 11, 2026 at 8:00 PM ET.
Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last released its earnings results on Thursday, February 26th. The company reported ($0.75) earnings per share (EPS) for the quarter. The firm had revenue of $0.31 million for the quarter. Anteris Technologies Global had a negative return on equity of 536.04% and a negative net margin of 4,921.27%. On average, analysts expect Anteris Technologies Global to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Anteris Technologies Global Stock Up 1.8%
AVR stock traded up $0.11 during trading hours on Tuesday, reaching $6.24. 143,949 shares of the stock were exchanged, compared to its average volume of 1,125,485. The firm’s 50-day moving average is $5.88 and its 200-day moving average is $5.28. Anteris Technologies Global has a 12 month low of $2.85 and a 12 month high of $6.95. The company has a debt-to-equity ratio of 0.01, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $606.72 million, a price-to-earnings ratio of -2.43 and a beta of 1.32.
Institutional Investors Weigh In On Anteris Technologies Global
Analyst Ratings Changes
A number of research firms have recently commented on AVR. Wells Fargo & Company began coverage on shares of Anteris Technologies Global in a research note on Wednesday, March 11th. They set an “overweight” rating and a $16.00 price objective for the company. Lake Street Capital restated a “buy” rating and set a $15.00 price objective on shares of Anteris Technologies Global in a research note on Friday, January 23rd. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $15.00 price objective on shares of Anteris Technologies Global in a research note on Friday, March 27th. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $15.33.
Check Out Our Latest Analysis on AVR
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Featured Articles
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
